EditorialEditorial
Managing Giant Cell Arteritis With Tocilizumab: Relapses and Adverse Events
Miguel Ángel González-Gay, Santos Castañeda and Iván Ferraz-Amaro
The Journal of Rheumatology December 2024, jrheum.2024-1204; DOI: https://doi.org/10.3899/jrheum.2024-1204
Miguel Ángel González-Gay
M.Á. González-Gay, MD, PhD, Medicine and Psychiatry Department, University of Cantabria, Santander, and Division of Rheumatology, IISFundación Jiménez Díaz, Madrid.
Santos Castañeda
S. Castañeda, MD, PhD, Division of Rheumatology, Hospital Universitario de La Princesa, IIS-Princesa, Madrid.
Iván Ferraz-Amaro
I. Ferraz-Amaro, MD, PhD, Division of Rheumatology, Hospital Universitario de Canarias, and Department of Internal Medicine, Universidad de La Laguna (ULL), Tenerife, Spain.
In this issue
The Journal of Rheumatology
Vol. 53, Issue 10
1 Oct 2026
Managing Giant Cell Arteritis With Tocilizumab: Relapses and Adverse Events
Miguel Ángel González-Gay, Santos Castañeda, Iván Ferraz-Amaro
The Journal of Rheumatology Dec 2024, jrheum.2024-1204; DOI: 10.3899/jrheum.2024-1204







